Discover

MIRA
MIRA Pharmaceuticals, Inc.
0.92
1 x 0.82
1 x 1.02
bid
ask
-
0.00
0.36%
1 @ 04:00 PM
0.94 +0.02 (2.54%)
Ytd-39.29%
1y-45.43%
0.91
day range
0.95
0.90
52 week range
2.45
Open0.91Prev Close0.92Low0.91High0.95Mkt Cap38.52M
Vol38.62KAvg Vol109.12KEPS-1.45P/E-0.63Forward P/E-2.14
Beta1.48Short Ratio0.47Inst. Own5.96%DividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg0.97200-d Avg1.221yr Est12.08
Income Statement
Operating Expenses1.10M
Research and Development Expense524.78K
Selling, General and Administrative Expense578.70K
Operating Income-1.10M
Net Income-1.15M
Net Income Common Stock-1.15M
Net Income Common Stock (USD)-1.15M
Consolidated Income-1.15M
Earnings per Basic Share-0.03
Earnings per Basic Share (USD)-0.03
Earnings per Diluted Share-0.03
Earning Before Interest & Taxes (EBIT)-1.15M
Earning Before Interest & Taxes (USD)-1.15M
Weighted Average Shares41.94M
Weighted Average Shares Diluted41.94M
Balance Sheet
Cash and Equivalents4.82M
Cash and Equivalents (USD)4.82M
Investments4.59M
Investments Current4.59M
Trade and Non-Trade Receivables35.44K
Current Assets9.43M
Total Assets9.46M
Current Liabilities114.76K
Total Liabilities114.76K
Accumulated Retained Earnings (Deficit)-40.73M
Shareholders Equity9.35M
Shareholders Equity (USD)9.35M
Assets Non-Current35.44K
Trade and Non-Trade Payables34.01K
Cash Flow
Net Cash Flow from Financing-330.61K
Net Cash Flow / Change in Cash & Cash Equivalents-1.53M
Issuance (Repayment) of Debt Securities -330.61K
Net Cash Flow from Operations-1.20M
Share Based Compensation107.59K